🏭

Pharmaceutical Companies

Major drug manufacturers and patient assistance programs

13 Providers

Sort: Recommended

Pfizer

Featured

Global pharmaceutical giant known for vaccines (COVID-19, pneumonia), oncology drugs, and cardiovascular medications. 175+ years in business.

Vaccine accessCancer treatmentPatient assistance needs

Updated Dec 2024

Varies by drug
View Details

Johnson & Johnson (Janssen)

Featured

#1 pharma company by 2024 Rx revenue ($53.5B). Janssen pharmaceutical division focuses on immunology, oncology, and neuroscience.

Autoimmune conditionsCancer treatmentMental health medications

Updated Dec 2024

Varies by drug
View Details

Novo Nordisk

Featured

Danish pharmaceutical leader in diabetes care and obesity treatments. Makers of Ozempic, Wegovy, and Rybelsus. +26% revenue growth in 2024.

Diabetes managementWeight loss (GLP-1)Insulin needs

Updated Dec 2024

$900-1,500/mo without help
View Details

Eli Lilly

Featured

Fastest-growing major pharma (+32% in 2024). Makers of Mounjaro, Zepbound, and affordable insulin. Industry leader in patient assistance.

Diabetes careWeight loss (Mounjaro/Zepbound)Affordable insulin

Updated Dec 2024

$35 insulin cap available
View Details

AbbVie

Featured

#2 pharma by 2024 Rx revenue ($52.7B). Known for immunology blockbusters Humira, Skyrizi, Rinvoq. Best-in-class patient support for rheumatology.

Autoimmune diseasesRheumatoid arthritisPsoriasisCrohn's disease

Updated Dec 2024

Biologics: $5,000-8,000/mo list
View Details

AstraZeneca

Featured

British-Swedish pharma with +18% growth in 2024 ($54.1B revenue). Strong in oncology, respiratory, and cardiovascular medications.

Cancer treatmentRespiratory conditions (asthma, COPD)Heart disease

Updated Dec 2024

Varies by drug
View Details

Merck & Co.

Global pharmaceutical company. Makers of Keytruda (revolutionary cancer immunotherapy), Gardasil (HPV vaccine), and essential medications.

Cancer treatment (Keytruda)Vaccines (Gardasil, flu)HIV treatment

Updated Dec 2024

Keytruda: $10,000+/mo list
View Details

Amgen

Pioneer biotech company (+17% growth in 2024). Leaders in biologics for cancer, bone health, and inflammatory conditions.

Bone health/osteoporosisCancer treatmentInflammatory conditionsBiosimilar alternatives

Updated Dec 2024

Biologics: $1,000-3,000/mo
View Details

Gilead Sciences

Leader in HIV treatment and prevention (Biktarvy, Descovy for PrEP). Also strong in hepatitis C cures and oncology.

HIV treatmentHIV prevention (PrEP)Hepatitis C cureAffordable antiviral access

Updated Dec 2024

HIV drugs: $2,000-4,000/mo list
View Details

Regeneron Pharmaceuticals

Innovative biotech known for Eylea (eye disease), Dupixent (eczema/asthma, with Sanofi), and COVID-19 antibody treatments.

Eye diseases (macular degeneration)Severe eczemaUncontrolled asthmaAllergies

Updated Dec 2024

Dupixent: $3,000+/mo list
View Details

Bristol Myers Squibb

Powerhouse in cancer treatment (Opdivo, Yervoy, Revlimid) and blood disorders. Strong patient access support programs.

Cancer treatmentBlood disorders (multiple myeloma)Heart conditions

Updated Dec 2024

Cancer drugs: $10,000+/mo
View Details

GSK (GlaxoSmithKline)

British pharmaceutical company leading in vaccines (Shingrix, flu), respiratory medications, and HIV treatments (ViiV Healthcare).

Vaccines (shingles is important for 50+)Asthma/COPDHIV treatment (via ViiV)

Updated Dec 2024

Shingrix: ~$200/dose
View Details

Sanofi

French pharmaceutical company known for Dupixent (with Regeneron), diabetes care (Lantus), vaccines, and rare disease treatments.

Diabetes management (Lantus)Eczema/allergies (Dupixent)VaccinesRare diseases

Updated Dec 2024

Dupixent: $3,000+/mo list
View Details

Related Resources